Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece

BACKGROUND: Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic treatment in Greece. Paliperidone palmitate (PP-LAI) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Einarson, Thomas R, Geitona, Maria, Chaidemenos, Alexandros, Karpouza, Vasiliki, Mougiakos, Theodoros, Paterakis, Periklis, Ploumpidis, Dimitrios, Potamitis-Komis, Dionyssios, Zilbershtein, Roman, Vicente, Colin, Piwko, Charles, Kakkavas, Panagiotis, Paparouni, Konstantina, Jensen, Rasmus C D, Hemels, Michiel E H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430591/
https://www.ncbi.nlm.nih.gov/pubmed/22747533
http://dx.doi.org/10.1186/1744-859X-11-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430591/
https://www.ncbi.nlm.nih.gov/pubmed/22747533
http://dx.doi.org/10.1186/1744-859X-11-18

Ejemplares similares